Major Players Lock Horns: Strategic Moves by Amgen, Sandoz, and Others to Capture Biosimilar Bevacizumab Market Share
The biosimilar bevacizumab market is a battleground for pharmaceutical giants, with Amgen, Sandoz, Pfizer, and Biocon leading the charge. These companies are deploying aggressive strategies—from R&D investments to strategic partnerships—to secure market dominance. Amgen, for instance, launched its biosimilar (Amjevita) in Europe in 2021, leveraging its existing oncology...
0 Yorumlar 0 hisse senetleri 261 Views 0 önizleme